Global Hypertension Drugs Market Anticipated to Grow at a CAGR of 1.12% During 2016-2024

Posted on 2018-09-19 by Goldstein Research in Healthcare // 0 Comments

New York, USA, 2018-Sep-19 — /EPR Network/ —

Hypertension Drugs Market

According to Goldstein Research, global hypertension drugs market is expected to reach USD 33.1 billion by 2024, growing at a CAGR of 1.12% over the forecast period 2016-2024. The rising geriatric population across the globe is driving the growth of the market. As per WHO statistics, nearly 22% of adults aged over 18yrs have increased blood pressure and nearly 52% American adults suffering from high blood pressure have their condition under control. Further, based on segmentation, systematic hypertension drugs segment accounted for the highest market share of 85.0% in 2016. Global hypertension drugs market is largely dominated by the North America region with a market share of 42.0% in 2016. The US has recently experienced growth in sales of hypertension drugs due to the spread of new disease-modifying therapies.

Download Exclusive Sample Report: https://www.goldsteinresearch.com/pressrelease/global-hypertension-drugs-market-size

Market Segmentation

On the basis of our in-depth analysis, Global Hypertension drugs Market can be segmented as follows:

By Analysis Basis

Systemic Hypertension Drugs
Pulmonary Hypertension Drugs

By Therapy Type

Calcium Channel Blockers
Diuretics
Beta Blockers Vasodilators
Angiotensin Converting Enzyme Inhibitor
Alpha Blockers
Angiotensin Receptor Blockers
Renin Inhibitors

By Region

North America Hypertension drugs Market Analysis, 2016-2024
Europe Hypertension drugs Market Analysis, 2016-2024
Middle East And Africa Hypertension drugs Market Analysis, 2016-2024
Latin America Hypertension drugs Market Analysis, 2016-2024
Asia Pacific Hypertension drugs Market Analysis, 2016-2024
Rest Of The World Hypertension drugs Market Analysis, 2016-2024

Browse Full Report: https://www.goldsteinresearch.com/report/global-hypertension-drugs-market-size-outlook

“Global Hypertension drugs Market Outlook 2024” contains detailed overview of the global hypertension drugs market. On the basis of our in-depth analysis, market can be segmented in terms of market segmentation by analysis basis, therapy type and geography.

The Global Hypertension Drugs Market Report highlights the competitive outlook of major global players that includes the business strategies, product portfolio, revenue distribution, financial analysis, R&D activities, and investments. The in-depth analysis of hypertension drugs market report will help the clients to assess their business strategies as per the competitive environment in the market space.

Major players of the global hypertension drugs market discussed in the report are: Lupin Limited, Novartis AG, Sun Pharmaceuticals LLC, Daiichi – Sankyo, Pfizer Inc., Sanofi S.A, AstraZeneca Plc., Johnson & Johnson Ltd., BoehringerIngelheim, and Merck & Co, Roche, Abbott, GlaxoSmithKline plc., AstraZeneca, Bayer AG, Gilead, Actelion, Symplmed Pharmaceuticals, Takeda Pharmaceuticals, United Therapeutics, Valeant Pharmaceuticals, XOMA, Yuhan, Ono Pharmaceutical, Northern Therapeutics, Mast Therapeutics, EigerBioPharmaceuticals,etc.

Further, Global Hypertension Drugs Market Analysis Report encompasses the major trends & growth opportunities, market dynamics and other growth factors. The Hypertension drugs Market outlook also comprises of key challenges for the market players, risk analysis, SWOT Analysis, USP Analysis, BPS analysis, and Market Attractiveness. The report also includes the expert analysis which provides a complete overview of the market post analysis of the economic, political, environmental & social factors of each region and country.

About Goldstein Research

Based in the US, Goldstein Research currently has a strong presence in the American and Asian countries. In the next five years, we strive to expand our reach to 50+ nations spanning across Europe, Asia and parts of the Middle East and Africa. We strive to realize a strong brand presence globally through our quality research and forecasting solutions.

Our mission is simple: to develop insightful business solutions, help our clients make powerful future decisions to keep them well ahead of the game which is the market, and leave a mark across businesses and communities through our well-defined ideas and clear-cut forecasts. Our market research reports provide in-depth analysis of global and regional variations along with competitors’ overview.

Our analysts working on healthcare market research reports to help various tech-giants, tech start-ups and entry players to assess the current and upcoming business scenario. We believe in the vigorous examination of the current market scenario and build around creative ideas and approaches that are most suitable to our clients’ needs and business agenda.